Bf. Becker et al., Catabolism of adenine nucleotides in the human heart before and after cardiac bypass surgery, DRUG DEV R, 45(3-4), 1998, pp. 159-165
Uric acid (UA) is a catabolite of the high-energy purine phosphates and of
purines in DNA and RNA. Thus, cardiac net release of UA could prevail in su
bjects with chronic myocardial ischemia and during coronary occlusion assoc
iated with cardiac artery bypass grafting surgery (CABG). However, in acute
reperfusion, reactive oxygen species could cause chemical degradation of u
rate, perhaps even giving rise to a negative coronary arteriovenous differe
nce. Blood was sampled simultaneously from the arterial and coronary venous
system of 24 patients undergoing elective CABG. Blood was immediately depr
oteinated (0.4 M HClO4) in the presence of the glutathione-scavenger N-ethy
lmaleimide (60 mM), and the supernatant was analysed for UA, purines, and g
lutathione by high performance liquid chromatography. Before the operation,
CABG patients revealed a small, but significant net production of UA in th
e heart (+28 mu mol/liter whole blood; arterial level, 223 +/- 71 mu M; mea
n +/- SD). There were no coronary differences for adenosine, inosine, or hy
poxanthine. UA release was not elevated in early reperfusion after cardiac
arrest and tended to decrease by 20-40 min of reperfusion (coronary sinus U
A 10-18 mu M above arterial level, not significant). Adenosine levels were
<0.2 mu M at all times in all blood samples. Coronary sinus (CS) inosine le
vels rose approximately 10-fold during early reperfusion to 2 mu M (not sig
nificant). However, CS hypoxanthine increased significantly from 8 (+/-3) t
o 35 (+/-14) mu M at 1 min reperfusion, but after 5 min had returned to 15
mu M. There was a net release of reduced glutathione from the hearts before
intervention, and individual changes in coronary glutathione levels were a
pproximately parallel to those of urate in early reperfusion. Surprisingly,
urate release did not correlate to the duration of cardiac ischemia (cross
clamp time). Thus, in human hearts with chronic ischemia, myocardial releas
e of uric acid is approximately 10-30% higher than the arterial input, indi
cative of a pronounced catabolic state of the tissue. Metabolic recovery af
ter CABG requires more than 1 h. Hypoxanthine (and not urate) is the better
marker of acute myocardial nucleotide catabolism in early postischemic rep
erfusion. Adenosine underlies a tight homeostasis in the coronary system. T
he correlation of urate and glutathione release suggests that membrane pert
urbation may accompany and/or contribute to nucleotide catabolism. Drug Dev
. Res. 45:159-165, 1998. (C) 1998 Wiley-Liss, Inc.